Estriol-induced fibrinolysis due to the activation of plasminogen to plasmin by nitric oxide synthesis in platelets

Blood Coagulation and Fibrinolysis

Volumn 26, Issue 3, 2015, Pages 316-323

  Jana, Pradipta ^a,b   Maiti, Smarajit ^b   Kahn, Nighat N ^c   Sinha, Asru K ^a  

^a Sinha Institute of Medical Science and Technology   (India)

^b VIDYASAGAR UNIVERSITY   (India)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

human serum albumin precursor; nongenomic expression of the estriol effect; plasmin; plasminogen activation

Indexed keywords

ESTRIOL; FIBRIN DEGRADATION PRODUCT; HUMAN SERUM ALBUMIN; MEMBRANE PROTEIN; METHEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMIN; PLASMINOGEN; TRITON X 100; PROTEIN BINDING; PROTEIN PRECURSOR; SERUM ALBUMIN;

ADULT; AMINO ACID ANALYSIS; ARTICLE; BLOOD CLOT LYSIS; CELL LYSATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCATCHARD PLOT; SYNTHESIS; THROMBOCYTE; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA; BIOSYNTHESIS; BLOOD; DRUG EFFECTS; ENZYME ACTIVATION; ISOLATION AND PURIFICATION; METABOLISM; THROMBOCYTE AGGREGATION; YOUNG ADULT;

ADULT; BLOOD PLATELETS; ENZYME ACTIVATION; ESTRIOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; PLASMINOGEN; PLATELET AGGREGATION; PLATELET-RICH PLASMA; PROTEIN BINDING; PROTEIN PRECURSORS; SERUM ALBUMIN; YOUNG ADULT;

EID: 84926519247     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000085     Document Type: Article

References (32)

1. Colman RW, Walsh PN. Mechanisms of platelet aggregation. In: Colman RW, Hirsh J, Maeder VJ, Salzman EW, editors. Haemostasis, thrombosis. Philadelphia, PA: JB Lippincott; 1987. pp. 594-605
2. Falk E. Dynamics in thrombus formation. Ann N Y Acad Sci 1992; 667:204-223
3. Fuster V, Badimon J, Chesebro JH, Fallon JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis 1996; 26:269-284
4. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257:2912-2919
5. Sherry S. Mechanism of fibrinolysis. In: William WJ, Beutler E, Ersler A, Rundels RW, editors. Hematology. Mcgraw-Hill; 1977. p. 1924
6. Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7:135-142
7. Summaria L, Hsieh B, Robbins KC. The specific mechanism of activation of human plasminogen to plasmin. J Biol Chem 1967; 242:4279-4283
8. Bhattacharyya M, Karmohapatra SK, Bhattacharya G, Bhattacharya R, Sinha AK. The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-a, a potent inhibitor of platelet aggregation and a thrombolytic agent. J Thromb Thrombolysis 2009; 28:173-184
9. Yao SK, Akhtar S, Scott-Burden T, Ober JC, Golino P, Buja LM, et al. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation 1995; 92:1005-1010
10. Sinha AK, Acharya K, Bhattacharya S, Mazumder S, Bauman WA, Kahn NN. Prevention of thrombosis in vivo by nitric oxide. Ind J Physiol Allied Sci 1998; 52:148-161
11. Karmohapatra SK, Chakraborty K, Kahn NN, Sinha AK. The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets. Am J Hematol 2007; 82:986-995
12. Chakraborty K, Sinha AK. The role of insulin as an antithrombotic humoral factor. Bioessays 2004; 26:91-98
13. Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets 2003; 14:421-427
14. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol 1982; 6:148-152
15. Dutta-Roy AK, Sinha AK. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. J Biol Chem 1987; 262:12685-12691
16. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988; 85:8664-8667
17. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin mediated dissolution of plasma clot. Blood Coagul Fibrinolysis 1995; 6:567-573
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement by the folin-phenol reagent. J Biol Chem 1951; 1193:265-275
19. Fazekas de St Groth S, Webster RG, Datyner A. Two new staining procedures for quantitative estimation of proteins on electrophoretic strips. Biochim Biophys Acta 1963; 71:377-391
20. Cleland WW. Dithiothreitol: a new protective reagent for SH groups. Biochemistry 1964; 3:480-482
21. Jana P, Maiti S, Ghosh R, Ghosh TK, Sinha AK. Estriol, a stimulator of nitric oxide synthesis in platelets, and its role as the powerful inhibitor of platelet aggregation. Cardiovasc Endocrinol 2013; 2:50-54
22. Kahn NN, Sinha AK. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase. J Biol Chem 1990; 265:4976-4981
23. Bhattacharjee KG, Bhattacharyya M, Halder UC, Jana P, Sinha AK. The role of estrogen receptor statusin neutrophils and maspin synthesis through nitric oxide production in human breast cancer. J Breast Cancer 2012; 15:181-188
24. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949; 51:660-672
25. Ghosh R, Karmohapatra SK, Bhattacharyya M, Bhattacharya R, Bhattacharya G, Sinha AK. The appearance of dermcidin isoform 2, a novel platelet aggregating agent in the circulation in acute myocardial infarction that inhibits insulin synthesis and the restoration by acetyl salicylic acid of its effects. J Thromb Thrombolysis 2011; 31:13-21
26. You HJ, Kim JY, Jeong HG. 17 beta-estradiol increases inducible nitric oxide synthase expression in macrophages. Biochem Biophys Res Commun 2003; 303:1129-1134
27. Kharitonov VG, Sundquist AR, Sharma VS. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J Biol Chem 1995; 270:28158-28164
28. Chakrabarti S, Lekontseva O, Peters A, Davidge ST. 17beta-Estradiol induces protein S-nitrosylation in the endothelium. Cardiovasc Res 2010; 85:796-805
29. Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005; 19:1951-1959
30. Logvinenko NS. Aldosterone: the mechanisms of molecular action. Ross Fiziol Zh Im I M Sechenova 2007; 93:746-761
31. Soldan SS, varez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 2003; 171:6267-6274
32. Banerjee D, Mazumder S, Sinha AK. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxaneA2. Blood Coagul Fibrinolysis (in press